
Gerald R. Ewoldt
Examiner (ID: 4358, Phone: (571)272-0843 , Office: P/1644 )
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1644 |
| Total Applications | 1060 |
| Issued Applications | 256 |
| Pending Applications | 142 |
| Abandoned Applications | 661 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5397319
[patent_doc_number] => 20090317382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'USE OF EFFECTOR-FUNCTION-DEFICIENT ANTIBODIES FOR TREATMENT OF AUTO-IMMUNE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/096196
[patent_app_country] => US
[patent_app_date] => 2006-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 37086
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20090317382.pdf
[firstpage_image] =>[orig_patent_app_number] => 12096196
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/096196 | Use of effector-function-deficient antibodies for treatment of auto-immune diseases | Dec 14, 2006 | Issued |
Array
(
[id] => 5159409
[patent_doc_number] => 20070172453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-26
[patent_title] => 'Tolerogenic approach for type 1 diabetes'
[patent_app_type] => utility
[patent_app_number] => 11/606637
[patent_app_country] => US
[patent_app_date] => 2006-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15856
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20070172453.pdf
[firstpage_image] =>[orig_patent_app_number] => 11606637
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/606637 | Tolerogenic approach for type 1 diabetes | Nov 29, 2006 | Abandoned |
Array
(
[id] => 5177053
[patent_doc_number] => 20070178113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-02
[patent_title] => 'Superantigen conjugate'
[patent_app_type] => utility
[patent_app_number] => 11/604057
[patent_app_country] => US
[patent_app_date] => 2006-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13502
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20070178113.pdf
[firstpage_image] =>[orig_patent_app_number] => 11604057
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/604057 | Superantigen conjugate | Nov 21, 2006 | Abandoned |
Array
(
[id] => 4976841
[patent_doc_number] => 20070218072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'METHODS OF IMPROVING HEALTH-RELATED QUALITY OF LIFE IN INDIVIDUALS WITH SYSTEMIC LUPUS ERYTHEMATOSUS'
[patent_app_type] => utility
[patent_app_number] => 11/562174
[patent_app_country] => US
[patent_app_date] => 2006-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 39650
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0218/20070218072.pdf
[firstpage_image] =>[orig_patent_app_number] => 11562174
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/562174 | METHODS OF IMPROVING HEALTH-RELATED QUALITY OF LIFE IN INDIVIDUALS WITH SYSTEMIC LUPUS ERYTHEMATOSUS | Nov 20, 2006 | Abandoned |
Array
(
[id] => 5215627
[patent_doc_number] => 20070104708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Compositions, methods, and kits relating to resistin'
[patent_app_type] => utility
[patent_app_number] => 11/590736
[patent_app_country] => US
[patent_app_date] => 2006-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 40347
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20070104708.pdf
[firstpage_image] =>[orig_patent_app_number] => 11590736
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/590736 | Compositions, methods, and kits relating to resistin | Oct 30, 2006 | Abandoned |
Array
(
[id] => 5040250
[patent_doc_number] => 20070092532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-26
[patent_title] => 'Arthritis vaccines and methods'
[patent_app_type] => utility
[patent_app_number] => 11/586346
[patent_app_country] => US
[patent_app_date] => 2006-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8454
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20070092532.pdf
[firstpage_image] =>[orig_patent_app_number] => 11586346
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/586346 | Arthritis vaccines and methods | Oct 24, 2006 | Abandoned |
Array
(
[id] => 6574306
[patent_doc_number] => 20100129344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'MEDICAL USES AND THERAPIES BASED UPON THE ACTION OF AZUROCIDIN ON IGFBP-1'
[patent_app_type] => utility
[patent_app_number] => 12/091004
[patent_app_country] => US
[patent_app_date] => 2006-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 16986
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20100129344.pdf
[firstpage_image] =>[orig_patent_app_number] => 12091004
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/091004 | MEDICAL USES AND THERAPIES BASED UPON THE ACTION OF AZUROCIDIN ON IGFBP-1 | Oct 18, 2006 | Abandoned |
Array
(
[id] => 6595440
[patent_doc_number] => 20100062471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-11
[patent_title] => 'Biomarkers for Multiple Sclerosis and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/088228
[patent_app_country] => US
[patent_app_date] => 2006-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 53537
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20100062471.pdf
[firstpage_image] =>[orig_patent_app_number] => 12088228
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/088228 | Biomarkers for Multiple Sclerosis and Methods of Use Thereof | Sep 28, 2006 | Abandoned |
Array
(
[id] => 5178027
[patent_doc_number] => 20070179087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-02
[patent_title] => 'METHOD FOR TREATING INFLAMMATORY DISEASES USING HEAT SHOCK PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 11/534782
[patent_app_country] => US
[patent_app_date] => 2006-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16713
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0179/20070179087.pdf
[firstpage_image] =>[orig_patent_app_number] => 11534782
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/534782 | METHOD FOR TREATING INFLAMMATORY DISEASES USING HEAT SHOCK PROTEINS | Sep 24, 2006 | Abandoned |
Array
(
[id] => 5465110
[patent_doc_number] => 20090325310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'Innovativer TSH-R-Ab-Kit'
[patent_app_type] => utility
[patent_app_number] => 11/992563
[patent_app_country] => US
[patent_app_date] => 2006-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6992
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11992563
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/992563 | Innovative TSH-R-Ab-kit | Sep 24, 2006 | Issued |
Array
(
[id] => 5074823
[patent_doc_number] => 20070014798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'Antibodies to dendritc cells and human dendritic cell populations and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/524875
[patent_app_country] => US
[patent_app_date] => 2006-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 25313
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20070014798.pdf
[firstpage_image] =>[orig_patent_app_number] => 11524875
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/524875 | Antibodies to dendritc cells and human dendritic cell populations and uses thereof | Sep 21, 2006 | Abandoned |
Array
(
[id] => 5465684
[patent_doc_number] => 20090325884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'Method for Detecting Autoantibodies Formed in Rheumatoid Arthritis'
[patent_app_type] => utility
[patent_app_number] => 11/990227
[patent_app_country] => US
[patent_app_date] => 2006-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6319
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0325/20090325884.pdf
[firstpage_image] =>[orig_patent_app_number] => 11990227
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/990227 | Method for Detecting Autoantibodies Formed in Rheumatoid Arthritis | Aug 9, 2006 | Abandoned |
Array
(
[id] => 5415867
[patent_doc_number] => 20090041754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-12
[patent_title] => 'METHOD FOR IDENTIFYING TARGET PROTEIN OF DRUG AND METHOD FOR SCREENING THERAPEUTIC AGENT FOR DIABETES USING THE TARGET PROTEIN'
[patent_app_type] => utility
[patent_app_number] => 11/909031
[patent_app_country] => US
[patent_app_date] => 2006-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 31735
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20090041754.pdf
[firstpage_image] =>[orig_patent_app_number] => 11909031
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/909031 | Method for identifying target protein of drug and method for screening therapeutic agent for diabetes using the target protein | Aug 8, 2006 | Issued |
Array
(
[id] => 8421931
[patent_doc_number] => 08278420
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-02
[patent_title] => 'Composition and method for prevention and treatment of type I diabetes'
[patent_app_type] => utility
[patent_app_number] => 11/997996
[patent_app_country] => US
[patent_app_date] => 2006-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 28928
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11997996
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/997996 | Composition and method for prevention and treatment of type I diabetes | Aug 3, 2006 | Issued |
Array
(
[id] => 5068944
[patent_doc_number] => 20070190045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'Anti-CD3 and antigen-specific immunotherapy to treat autoimmunity'
[patent_app_type] => utility
[patent_app_number] => 11/498381
[patent_app_country] => US
[patent_app_date] => 2006-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 20885
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20070190045.pdf
[firstpage_image] =>[orig_patent_app_number] => 11498381
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/498381 | Anti-CD3 and antigen-specific immunotherapy to treat autoimmunity | Aug 2, 2006 | Abandoned |
Array
(
[id] => 5343262
[patent_doc_number] => 20090181912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'GLP/1/EXENDIN 4 IgG Fc FUSION CONSTRUCTS FOR TREATMENT OF DIABETES'
[patent_app_type] => utility
[patent_app_number] => 11/996776
[patent_app_country] => US
[patent_app_date] => 2006-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 18009
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20090181912.pdf
[firstpage_image] =>[orig_patent_app_number] => 11996776
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/996776 | GLP/1/exendin 4 IgG Fc fusion constructs for treatment of diabetes | Jul 26, 2006 | Issued |
Array
(
[id] => 5204984
[patent_doc_number] => 20070026465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-01
[patent_title] => 'Method for detecting GAD65 autoreactive T cells newly diagnosed type1 diabetic patients and in the prediabetic period'
[patent_app_type] => utility
[patent_app_number] => 11/492645
[patent_app_country] => US
[patent_app_date] => 2006-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6659
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20070026465.pdf
[firstpage_image] =>[orig_patent_app_number] => 11492645
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/492645 | Method for detecting GAD65 autoreactive T cells newly diagnosed type1 diabetic patients and in the prediabetic period | Jul 24, 2006 | Abandoned |
Array
(
[id] => 5533046
[patent_doc_number] => 20090232834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'Methods and Agents to Treat Autoimmune Diseases'
[patent_app_type] => utility
[patent_app_number] => 11/989011
[patent_app_country] => US
[patent_app_date] => 2006-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8801
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20090232834.pdf
[firstpage_image] =>[orig_patent_app_number] => 11989011
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/989011 | Methods and Agents to Treat Autoimmune Diseases | Jul 17, 2006 | Abandoned |
Array
(
[id] => 5264899
[patent_doc_number] => 20090117584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-07
[patent_title] => 'Non-Human mammalian Arthritis Model Featuring Human Antibodies Against Citrul-Linated Proteins'
[patent_app_type] => utility
[patent_app_number] => 11/922990
[patent_app_country] => US
[patent_app_date] => 2006-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5231
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20090117584.pdf
[firstpage_image] =>[orig_patent_app_number] => 11922990
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/922990 | Non-Human mammalian Arthritis Model Featuring Human Antibodies Against Citrul-Linated Proteins | Jun 28, 2006 | Abandoned |
Array
(
[id] => 5602273
[patent_doc_number] => 20060292618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-28
[patent_title] => 'Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance'
[patent_app_type] => utility
[patent_app_number] => 11/474162
[patent_app_country] => US
[patent_app_date] => 2006-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 23344
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20060292618.pdf
[firstpage_image] =>[orig_patent_app_number] => 11474162
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/474162 | Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance | Jun 22, 2006 | Abandoned |